ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002

Press/Media

Period	27 Aug 2021

Media coverage

Title	ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002
Media name/outlet	Biotechgate
Country/Territory	Switzerland
Date	27/08/21
URL	www.biotechgate.com/gate/v3/news_details.php?news_id=262729&page_id=?next=1
Persons	Jesse Cedarbaum